A study led by Columbia obstetricians has shown that a new intrauterine device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in real-world situations ...

Please provide your email address to receive an email when new articles are posted on . Levonorgestrel-releasing intrauterine system users vs. nonusers had an increased risk for breast cancer. Breast ...

In a large New York healthcare system, 11.4% of intrauterine device (IUD) removals required complex procedures, with age and language barriers significantly affecting complication rates. Among ...

Please provide your email address to receive an email when new articles are posted on . Treatment success for the JADA system was high for both vaginal and cesarean births. Overall, 2.8% of women in ...

A study led by obstetricians has shown that a new device can rapidly control postpartum hemorrhage, a major cause of severe maternal morbidity and death, in a wide range of patients. A study led by ...

The study was a multicentre, double-blind, randomised, placebo-controlled trial of mepivacaine (10 mL of 20 mg/mL) vs placebo (0.9 mg/mL sodium chloride) instilled into the uterus 2 minutes before IUD ...